GlassScriptPhysician profile
Mudassir Nawaz
NPI 1396737789
$10,321.96
in general payments reported to CMS, 2019-2025
46 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $1,438 · 2021: $1,681 · 2022: $1,344 · 2023: $1,651 · 2024: $1,445 · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,297 · Education: $56.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,296.94 |
| Education | $56.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,206.64 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Glaxosmithkline, LLC. | $1,173.30 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $903.16 | 2019-2025 | Otezla, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $827.58 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $777.31 | 2019-2024 | |
| Novo Nordisk INC | $592.86 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Mylan Specialty L.P. | $577.06 | 2019-2024 | Yupelri |
| Abbvie INC. | $410.09 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $391.27 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $358.07 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $341.43 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $248.43 | 2019-2023 | Verquvo, Steglatro, Belsomra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $234.49 | 2019-2025 | Xifaxan, Relistor |
| Abbott Laboratories | $197.17 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $146.00 | 2022-2025 | Dexcom G6 Transmitter |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $139.39 | 2020-2024 | Eliquis |
| Sanofi-Aventis U.S. LLC | $138.30 | 2019-2022 | |
| Inogen, INC. | $131.09 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Exact Sciences Corporation | $125.85 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Teva Pharmaceuticals USA, INC. | $113.99 | 2019-2020 | |
| Astellas Pharma US INC | $113.79 | 2019-2023 | Veozah, Myrbetriq |
| Axsome Therapeutics, INC. | $103.87 | 2023-2025 | Auvelity |
| Sumitomo Pharma America, INC. | $100.08 | 2024-2025 | Gemtesa |
| Baxter Healthcare | $89.67 | 2024 | Hillrom - Monarch Airway Clearance System |
| Janssen Pharmaceuticals, INC | $83.87 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $77.63 | 2022-2025 | Gvoke Hypopen |
| Viatris Specialty LLC | $64.42 | 2025 | Yupelri |
| Verona Pharma, INC. | $61.52 | 2025 | Ohtuvayre |
| Lundbeck LLC | $55.46 | 2019-2024 | Rexulti |
| Sunovion Pharmaceuticals INC. | $54.75 | 2019-2020 | |
| Eisai INC. | $50.65 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $43.47 | 2021 | |
| Allergan, INC. | $40.55 | 2019-2020 | |
| Amarin Pharma, INC. | $36.94 | 2019-2021 | |
| Corcept Therapeutics | $33.08 | 2025 | Korlym |
| Radius Health, INC. | $32.99 | 2020 | |
| Bardy Diagnostics, INC. | $32.56 | 2020-2021 | |
| Insulet Corporation | $31.03 | 2021-2022 | |
| Antares Pharma, INC. | $30.67 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $28.81 | 2024 | Ultomiris |
| Almatica Pharma LLC | $26.05 | 2025 | Teriparatide |
| Inspire Medical Systems, INC. | $24.67 | 2025 | Inspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.65 | 2025 | Caplyta |
| Philips North America LLC | $19.44 | 2022 | |
| Idorsia Pharmaceuticals US INC | $18.63 | 2023 | Quviviq |
| Currax Pharmaceuticals LLC | $13.23 | 2024 | Contrave, Onzetra Xsail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mudassir Nawaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.